Changing the Narrative for Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Ulcerative Colitis (UC) Patients
The RA, PsA, and UC Narrative initiatives were created to help patients living with these conditions, and the physicians who treat them, develop resources to break down communication barriers and change expectations to improve disease management.
By working with advocacy partners, health care providers and patients in 22 countries around the world, Pfizer created the Narrative initiatives to elevate the voices of patients and further understand how they are impacted by their disease. Through primary research, the initiatives uncovered insights to help identify real-world needs and concerns about patient care.
During 2018, each Narrative reached major milestones by leveraging research outputs to engage global and local stakeholders in new conversations about improving patient care - becoming a tangible realization of our Patients First commitment.
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families